News
Kytopen and BlueWhale Bio join forces to develop non-viral cell therapy manufacturing workflow. ...
September 09, 2025
Kytopen appoints new board of directors as part of its commercial expansion of the Flowfect Tx®...
June 03, 2025
Kytopen and Bio-Techne announce partnership on an integrated cellular engineering workflow to...
May 08, 2025
Kytopen announces expansion of its partnership program into Europe with its agreement with T-CURX...
February 13, 2025
Successful engineering of macrophages is of critical importance for next-generation...
October 22, 2024
Charles River generated best-in-class data with Kytopen’s Flowfect™ technology in comparative...
September 17, 2024
Kytopen awarded competitive phase II SBIR fast-track funding for “Non-Activated Natural Killer...
August 13, 2024
Kytopen announces the first implementation of its GMP compliant Flowfect Tx™ cellular engineering...
July 16, 2024
Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer ...
April 09, 2024